MyFinsight
Home
Blog
About
Net income (loss)
$192,800K
(123.77%↑ Y/Y)
Intangible asset
amortization
$170,000K
(-46.30%↓ Y/Y)
Acquired in-process
research and development
$77,000K
(-91.50%↓ Y/Y)
Proceeds from maturity of
investments
$720,000K
(-7.69%↓ Y/Y)
Share-based compensation
$73,300K
(-44.53%↓ Y/Y)
Accounts payable
$28,500K
(340.84%↑ Y/Y)
Acquisition accounting
inventory fair value...
$16,600K
(-75.22%↓ Y/Y)
Depreciation
$9,100K
(-59.25%↓ Y/Y)
Accrued liabilities
$8,500K
(111.28%↑ Y/Y)
Provision for losses on
accounts receivable and...
$7,500K
(10.77%↑ Y/Y)
Prepaid expenses and
other assets
-$4,900K
(40.33%↑ Y/Y)
Non-cash interest
expense
$4,900K
(-77.64%↓ Y/Y)
Net cash provided by
operating activities
$415,700K
(-19.85%↓ Y/Y)
Net cash provided by
(used in) investing...
$354,900K
(143.82%↑ Y/Y)
Canceled cashflow
$177,400K
Canceled cashflow
$365,100K
Net increase
(decrease) in cash and cash...
-$224,500K
(81.64%↑ Y/Y)
Canceled cashflow
$770,600K
Proceeds from employee
equity incentive and...
$22,700K
(3.45%↑ Y/Y)
Accounts receivable
$44,900K
(526.40%↑ Y/Y)
Deferred tax benefit
-$38,700K
(64.90%↑ Y/Y)
Income taxes payable
-$37,700K
(-163.61%↓ Y/Y)
Inventories
$29,900K
(-51.66%↓ Y/Y)
Other liabilities
-$23,800K
Other non-cash
transactions
$2,400K
(134.08%↑ Y/Y)
Acquisition of investments
$270,000K
(-60.30%↓ Y/Y)
Acquired in-process
research and development
$77,000K
Purchases of property,
plant and equipment
$18,100K
(-32.58%↓ Y/Y)
Net cash used in
financing activities
-$994,500K
(-6.02%↓ Y/Y)
Canceled cashflow
$22,700K
Effect of exchange
rates on cash and cash...
-$600K
(-109.50%↓ Y/Y)
Repayment of 2026 notes
$1,000,000K
Payment of employee
withholding taxes related to...
$9,500K
(-86.31%↓ Y/Y)
Repayments of long-term
debt
$7,700K
(-98.99%↓ Y/Y)
Back
Back
Cash Flow
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)
source: myfinsight.com